Related Experiment Video
Updated: Apr 27, 2026
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer: A Randomized
Carolina Chabrera1, Adelaida Zabalegui, Marta Bonet
1Author Affiliations: School of Health Science-TecnoCampus, Department of Nursing, University Pompeu Fabra, Mataró (Ms Chabrera); Departments of Oncology (Ms Chabrera and Dr Font) and Radiation Oncology (Dr Caro), Catalan Institute of Oncology, Badalona; Hospital Clinic, Barcelona (Dr Zabalegui); Oncology Institute of Vallés, Terrassa (Dr Bonet); Department of Urology, University Hospital Germans Trias i Pujol, Badalona (Dr Areal); and Center for Research in Environmental Epidemiology-CREAL, Barcelona (Dr González), Spain.
Background:
Decision aids provide balanced information about the benefits and risks of treatment options and improve the match between patient preferences and the treatment received.
Objective:
To assess the impact of a decision aid regarding the treatment options for patients with localized prostate cancer.
Methods:
A 2-arm randomized controlled trial was used to compare booklet patient decision aid (intervention group n = 61) with standard information for localized prostate cancer (control group n = 61). The study was conducted at 3 hospitals between 2011 and 2013. The main outcome measures were knowledge, decisional conflict, satisfaction with the decision-making process, and coping.
Results:
The respective mean Decisional Conflict Scale scores before and after the intervention were 53.0 ± 16.9 and 31.2 ± 10.2 in the intervention group and 49.1 ± 13.7 and 51.7 ± 13.3 in the control group (P < .001). Mean Knowledge scores were 38.6 ± 16.5 and 75.7 ± 19.0 in the intervention group and 42.0 ± 17.6 and 49.9 ± 16.0 in the control group (P < .001). Mean Satisfaction With Decision Scale scores were 81.1 ± 8.92 and 95.7 ± 6.89 in the intervention group and 82.5 ± 12.0 and 79.3 ± 10.3 in the control group (P < .001).
Conclusions:
Decision aid not only improved patient knowledge about localized prostate cancer and its treatment and their satisfaction with decision making but also decreased their decisional conflict.
Implications For Practice:
Decision aid represents a rather innovative approach for a health insurance fund to develop and offer this format of information and decision support. This opens a new field of study for nurses to empower patients in the decision-making process and develop new roles in this area.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013